US Medical Billing
Payer Contracts & Reimbursement

Value-Based Contract Basics: What the Word Actually Requires

Most arrangements described as value-based are fee-for-service with a quality bonus attached. That can be a perfectly good deal, but it is not what the phrase means in the one place the federal government defined it — and the definition is worth knowing, because it names the four things a practice should be able to point to in the contract before signing, whether or not the arrangement is trying to fit a safe harbor at all.

Updated 10 min read

On this page

Key takeaways

Where the definition lives, and why that matters

There is no general federal statute defining a value-based contract for commercial purposes, and the phrase is used loosely enough in the market to mean almost anything. But there is one place the government defined the terms carefully, and it is a revealing one: the anti-kickback safe harbor regulations, where a set of definitions was added specifically for these arrangements.

The location is not an accident. A value-based arrangement moves money between parties who send each other patients, which is precisely the pattern the anti-kickback statute exists to police. The definitions were written to draw a line between an arrangement designed to improve care and one designed to reward referrals — and once you read them that way, the specific requirements stop looking bureaucratic and start looking like a checklist of the things that distinguish the two.

What this article is not doing

The four things the definition asks for

A value-based purpose, from a closed list
Coordinating and managing the care of a target patient population; improving the quality of care for it; appropriately reducing the costs to, or growth in expenditures of, payors without reducing the quality of care; or transitioning from payment based on the volume of items and services to payment based on quality and the control of costs. Four purposes, and the qualifier inside the third is doing real work — cost reduction on its own is not one of them.
A target patient population, defined in advance
An identified population selected using legitimate and verifiable criteria that are set out in writing before the arrangement commences and that further the purpose. This is the requirement with the most practical bite, and it is discussed on its own below.
Value-based activities that serve the purpose
Providing an item or service, taking an action, or refraining from taking one — each reasonably designed to achieve at least one of the purposes. The inclusion of refraining is deliberate and useful: not doing something can be the valuable act, which is a thing fee-for-service structurally cannot pay for.
Accountability and a governing document
Where the arrangement runs through an enterprise of collaborating participants, the definition expects an accountable body or person responsible for financial and operational oversight, and a governing document describing the enterprise and how the participants intend to achieve its purposes. Someone is answerable, and the plan is written down.

And one exclusion that explains everything else

Define the population before the results, not after

The requirement that the target patient population be identified on legitimate and verifiable criteria, in writing, in advance, reads like a compliance formality. It is actually the most useful contracting discipline in the whole definition, and it is the one commercial arrangements most often fail on their own terms.

The reason is straightforward: performance is measured against a population, so whoever defines the population defines the result. A cohort selected after the outcomes are visible can be made to demonstrate almost anything, in either direction. Insisting the criteria are written down first — and that they are verifiable, meaning the practice can independently reproduce who is in and who is out — is what makes the eventual settlement something either party can check rather than something one party asserts.

  1. Get the attribution method in writing

    How a patient joins the population — by their own election, by an algorithm reading claims history, by a visit pattern, by default — and when. Whether attribution is decided at the start of the period, at the end, or continuously changes what the practice is accountable for and when it can know.
  2. Establish that the practice can reproduce the list

    A population the practice cannot independently identify is a population it cannot manage, and a settlement it cannot audit. If the plan supplies the roster, the agreement should say how often and in what form; if it is derived from a rule, the rule has to be specific enough to run.
  3. Find the measure specifications, not just the measure names

    The contract usually names measures and locates their definitions elsewhere — in an appendix, a program manual, or a document incorporated by reference. The specification is the term that decides the money: numerator, denominator, exclusions, the data source, and the period. A measure named without its specification is not yet a contract term.
  4. Settle when the money is calculated and how it is disputed

    There is a lag between the period and its settlement, because claims run out. The agreement should say how long that is, what data it uses, whether the practice sees the calculation, and what happens when the practice disagrees with it.

Incorporation by reference is where the real terms usually are

Upside, downside, and which contract you are actually reading

Underneath the vocabulary, value-based arrangements divide on a simple question: can the practice end the period owing money? An arrangement that can only pay a bonus transfers no financial risk at all, whatever it is called. One with downside exposure is a risk-bearing contract, and it should be read with the same questions asked of a capitation agreement — what happens when utilization or cost runs past the assumption, and whether anything caps the exposure.

Two shapes of value-based arrangement, and what each one actually requires the practice to be able to do.
Two shapes of value-based arrangement, and what each one actually requires the practice to be able to do.
ShapeWhat it demands of the practice
Upside only — a payment for meeting targetsMeasurement capability, primarily. The practice needs to capture and report whatever the measures require, know its own performance before the plan tells it, and be able to check the settlement. The downside of failure is that the bonus does not arrive.
Two-sided — the practice can oweEverything above, plus the ability to carry a loss and to see it coming. That means timely cost and utilization data from the plan rather than a retrospective statement, some cap or corridor on the exposure, and an honest view of whether the practice can influence what it is now accountable for.

The question that separates them in practice is not how much money is at stake but how early the practice can see where it stands. An arrangement with downside risk and annual reporting is one where the first news of a loss arrives after every opportunity to prevent it has passed.

One last structural point, and it is the one that catches practices which have run these arrangements successfully elsewhere: the measures have to be things this practice can actually move. A measure driven mostly by patient behavior, by another provider's decisions, or by a population characteristic the practice does not select for will produce a result that is largely noise — and a contract that pays on noise is a lottery in either direction, regardless of how carefully the rest of it was drafted.

Common questions

Is a quality bonus a value-based contract?

In ordinary usage people call it one. Against the federal definition it may well not be: that definition asks for a purpose drawn from a closed list, a target patient population identified on verifiable criteria in writing before the arrangement starts, and activities reasonably designed to achieve the purpose. A bonus bolted onto fee-for-service with no defined population and no stated purpose has none of that structure. It can still be a good deal — the point is not that the label is forbidden, but that the definition names four things worth having in the contract regardless of what it is called.

Why are these definitions in the anti-kickback regulations?

Because that is where the risk was thought to be. These arrangements move money between parties who refer patients to each other, which is the pattern the anti-kickback statute exists to police, so the government defined the terms in the course of creating safe harbors for arrangements it wanted to permit. The clearest evidence is the exclusion built into the definition of a value-based activity: it covers providing an item or service, taking an action, or refraining from one — and states expressly that it does not include making a referral.

How much does it matter when the patient population is defined?

It is the single most consequential term, and the regulation's answer is unambiguous: the criteria must be legitimate and verifiable and must be set out in writing in advance of the arrangement commencing. The reason is not formalism. Performance is measured against a population, so whoever defines the population defines the result — a cohort chosen after outcomes are visible can be made to show almost anything. Written first, and reproducible by the practice independently, is what makes the settlement checkable.

What should we ask for that practices commonly forget?

The measure specifications rather than the measure names, and the data feed. A contract will name measures and locate their definitions in an appendix or a document incorporated by reference — and that document holds the numerator, denominator, exclusions, data source and period, which is where the money actually is. Alongside it, ask how often the practice receives performance and cost data. An arrangement with real downside exposure and retrospective annual reporting tells you where you stood only after nothing can be done about it.

Is capitation a value-based arrangement?

Not by itself. Capitation is a payment mechanism — a fixed amount per covered patient per period — and it transfers utilization risk without saying anything about quality. A capitation with no quality component is a budget with risk attached, which is a coherent arrangement but not one that matches the definition's insistence on a purpose about coordinating care, improving quality, or reducing cost without reducing quality. Many value-based arrangements do use capitation as the payment vehicle, and those are read on both dimensions at once.

Authoritative sources

  • 42 CFR § 1001.952 — Exceptions (anti-kickback safe harbors), value-based definitions (opens in a new tab)

    Defines a value-based purpose as coordinating and managing the care of a target patient population, improving the quality of care for it, appropriately reducing the costs to or growth in expenditures of payors without reducing the quality of care, or transitioning from volume-based to quality-and-cost-based payment; defines a target patient population as one selected using legitimate and verifiable criteria set out in writing in advance of the arrangement and furthering the value-based purpose; defines a value-based activity as providing an item or service, taking an action, or refraining from taking an action where reasonably designed to achieve a value-based purpose, and states that it does not include the making of a referral; and defines a value-based enterprise as participants collaborating toward a value-based purpose with an accountable body or person responsible for financial and operational oversight and a governing document describing how they intend to achieve it.

Ready to improve your revenue cycle?

Tell us about your practice and we’ll tell you where we would start.